In addition, Flavokawain A exerts a beneficial impact on a rat model of surgically induced EMs by means of modulating the PI3K/AKT signaling pathway to reduce angiogenesis 40. This evidence concerns the gene AKT1 and eosinophilia-myalgia syndrome.